semaglutide fda approval Approves Oral as the First Oral GLP-1 Pill UT San Antonio study: As
Description
Understanding these baseline risk factors is crucial for appropriate patient counseling and risk stratification
At lower doses, you may need to discard remaining solution after 4 weeks if significant amounts remain
doi: 10.1016/j.cgh.2024.03.006
And for many, this approach has workedthough it requires consistency, patience, and discipline
GLP-1 RAs are known to delay gastric emptying and can exacerbate constipation, particularly in patients with pre-existing risk factors, such as prior abdominal surgery, adhesive disease, cirrhosis with ascites, and the use of multiple constipating medications
